• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Paladin Labs Inc


Ticker Delisted

Snapshot for Paladin Labs Inc (5PL)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for 5PL

No chart data available.
  • 5PL:GR 95.169
  • 1M
  • 1Y
Interactive 5PL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 5PL

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) 54.1907
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2013) 2.4730
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 5PL

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for 5PL

Paladin Labs, Inc. develops, markets, and distributes pharmaceuticals. The Company offers a variety of products in urology, dermatology, rheumatology, and other specialty markets.

Jonathan Ross GoodmanChairman/Pres/CEO/Co-FounderMark A BeaudetInterim Pres & CEO/Co-Founder
Mark H NawackiExec VP:Corporate & Product DevSamira SakhiaChief Financial Officer
More Company Profile & Key Executives for 5PL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil